- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 107
Duolingo translates pitch to collect $10m
General Atlantic has supplied equity and secured shares through a secondary transaction, and will aid the CMU-founded language app developer's international growth objectives.
Apr 29, 2020Corporates help cover Qoala's series A
The online insurance provider received $13.5m in a round led by Centauri Fund and backed by MassMutual Ventures, MDI Ventures and Central Capital Ventura.
Apr 29, 2020InnovoPro invites Migros for $15m series B
The retail group returned to take part in a series B round that will find the expansion of chickpea-based protein developer InnovoPro's production capacity.
Apr 27, 2020Corporate venturing deal net: 20-24 April 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Apr 24, 2020Leuven Instruments loops in series B financing
CAS Star has led a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.
Apr 24, 2020Leuven Instruments loops in series B financing
Red Star Macalline was among the participants in a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.
Apr 24, 2020Tridge tracks $11m for series B
Forest Partners and Activant Capital have invested $11m in the SoftBank-backed agriculture trading hub.
Apr 23, 2020FoRx picks up $10m in seed round
M Ventures and Novartis Venture Fund co-led a round for the oncology drug startup that also featured fellow corporate venturing unit Pfizer Ventures.
Apr 23, 2020H1 Insights pinpoints series A funding
Novartis DRX was among the investors in a $12.9m for the medical personnel database operator that lifted its overall funding close to $20m.
Apr 23, 2020Phost’in bags $11.1m
Satt AxLR-allied Phost'in Therapeutics has secured funding to progress cancer drugs targeting glycosylation and the body's immune system.
Apr 23, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


